Search results (17)
« Back to NewsA Breakthrough in Early Epigenetic Markers for Childhood Leukemia
25 November 2024
A new study by Professor Terry Dwyer and 17 global partner institutions has revealed crucial molecular markers found in blood that are linked to the later development of acute lymphoblastic leukemia (ALL) - the most common type of cancer in children.
Prof. Ahmed and Dr. Zaarour secure funds to develop ovarian cancer vaccine
4 October 2024
Professor Ahmed Ahmed and Dr Nancy Zaarour have received funding from Cancer Research UK to undertake preclinical testing of a preventative vaccine for ovarian cancer. The vaccine would teach the immune system to recognise and attack the earliest stages of ovarian cancer. The team will receive up to £600,000 for the study over the next three years to support lab research into the vaccine.
International Recognition for NDWRH Extracellular Vesicle Work
6 June 2024
Associate Professor at the Nuffield Dept of Women's & Reproductive Health elected Secretary General and recognised for special award.
Pioneering Project Showcased at Prototypes for Humanity Exhibition in Dubai
5 January 2024
Among the standout projects featured at the Prototypes for Humanity Exhibition in Dubai was the groundbreaking work of our very own Prof. Helen Townley and her student, Ben White. Their project, titled “Radio wave-activated chemotherapy" drew significant attention for its inventive approach to addressing critical issues in cancer treatment....
First woman in UK receives dose of therapeutic HPV vaccine
5 July 2021
NDWRH and Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of vaccines for the treatment and prevention of infectious diseases and cancer, see the first woman in the UK receive the first dose of a novel therapeutic HPV vaccine for the HPV001 clinical trial in Oxford.
Singula Bio provides new hope for cancer with diverse, individualised therapies
24 February 2021
The Oxford spinout will draw on a multi-discipline approach for therapies which work with a patient to eliminate cancer.
Understanding the origins of ovarian cancer
10 October 2019
Research into the early detection of ovarian cancer by the Ahmed group, receives a boost thanks to a gift of £43,000 from the Dianne Oxberry Trust.
Cancer hijacks natural cell process to survive
27 June 2017
Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease, according to new research led by Professor Ahmed Ahmed at the Nuffield Department of Obstetrics & Gynaecology. This discovery could help clinicians identify and inhibit the process, giving them much better control of a person's cancer.
Cannabinoid biomedicine research programme launched
16 March 2017
Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.
Professor receives award for his work on ovarian cancer
21 November 2016
Professor Ahmed is seen here receiving an award for `International Scientist of the Year' from the United Arab Emirates Genetics Diseases Association (UAEGDA). The award was presented by His Royal Highness Sheikh Nahyan Al Nahyan, UAE Minister of Youth and Culture.
New research routes for scientists trying to detect ovarian cancer
3 August 2016
Oxford University researchers have found a way to detect ovarian cancer early and identified an enzyme that is key in making ovarian cancer more deadly. Their results, published in two journals, provide new research routes for scientists trying to detect and beat the disease.
Prize for best poster presentation
15 June 2016
Postdoctoral Research Assistant Yiyan Zheng has won one of three prizes for best poster presentations.
Future Fertility Trust charity launched
13 June 2016
A pioneering new charity dedicated to helping young people at risk of infertility has been set up by specialists from the Nuffield Department of Obstetrics & Gynaecology, the Institute of Research Studies at the University of Oxford, and the Oxford University Hospitals NHS Foundation Trust.
Children with cancer given hope of having a family in the future
17 December 2015
More children in England and Wales, who are at high risk of being infertile after cancer treatment, will be given the chance of a family later in life thanks to a major donation to Oxford University Hospitals NHS Foundation Trust.
'Starvation gene' could make resistance futile for ovarian cancer cells
17 August 2010
Dr Ahmed talks about the research in the Ovarian Cancer Research Laboratory